{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-048998","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2025-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.306294+00:00","generated_at":"2026-05-20T06:36:35.339703+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CERO Therapeutics shareholders approve 1:20 reverse stock split, increase share reserve by 2M shares","bullets":["Reverse stock split ratio set at 1:20, effective 12:01 a.m. ET on June 10, 2025, subject to regulatory processes.","Shareholders approved amendment to 2024 Equity Incentive Plan, increasing authorized shares by 2,000,000 shares.","Election of Class I directors Michael Byrnes and Lindsey Rolfe, M.D. to serve until 2028 annual meeting.","Ratification of Wolf & Company, P.C. as independent registered public accounting firm for fiscal year 2025.","Also approved issuance of shares upon exercise of February 2025 warrants and conversion of Series D preferred below market price."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-048998","json":"https://secwatch.observer/filing/0001213900-25-048998.json","markdown":"https://secwatch.observer/filing/0001213900-25-048998.md","text":"https://secwatch.observer/filing/0001213900-25-048998.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390025048998/0001213900-25-048998-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390025048998/ea0243837-8k_cero.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T06:36:35.339703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}